Dcc Netrin 1 Receptor Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
|
| Protein Name | DCC Netrin 1 Receptor Protein |
| Gene | DCC |
| UniProt ID | Q9Y266 |
| PDB ID | 5YJT, 5YJZ |
| Molecular Weight | ~175 kDa |
| Subcellular Localization | Plasma membrane, cytoplasm |
| Protein Family | Ig superfamily, DCC family |
DCC (Deleted in Colorectal Cancer) is the primary receptor for the axon guidance molecule netrin-1, playing crucial roles in neuronal development, circuit formation, and cellular survival. As a dependence receptor, DCC induces apoptosis in the absence of its ligand netrin-1, making it a key regulator of neuronal viability throughout life.
DCC is a type I transmembrane protein with the following domain architecture:
The full-length DCC protein consists of approximately 1,447 amino acids, with the extracellular domain comprising about 1,100 residues.
¶ Axon Guidance and Neuronal Migration
DCC functions as the primary netrin-1 receptor mediating long-range axon attraction:
- Axon Guidance: Netrin-1 gradient sensing by DCC directs axonal growth cones toward or away from the midline
- Cortical Neuronal Migration: DCC-netrin signaling regulates radial migration of cortical neurons during development
- Midline Crossing: DCC-expressing commissural axons are attracted to the midline by netrin-1
- Spinal Cord Development: DCC guides spinal cord commissural axon projection
DCC acts as a dependence receptor—a dual-function receptor that promotes survival in the presence of ligand but triggers apoptosis when ligand is absent:
- With Netrin-1: Activates pro-survival signaling (PI3K/AKT, MAPK/ERK pathways)
- Without Netrin-1: Induces apoptosis through caspase activation and mitochondrial pathways
This mechanism is crucial for:
- Developmental cell death
- Elimination of inappropriate neuronal connections
- Tissue homeostasis
DCC activates multiple downstream signaling cascades:
- FAK/SRC Pathway: Cell adhesion and cytoskeletal reorganization
- PI3K/AKT Pathway: Pro-survival signaling, blocks caspase activation
- MAPK/ERK Pathway: Neuronal differentiation and axon outgrowth
- Rho GTPase Pathways: Actin cytoskeleton dynamics for growth cone steering
DCC dysfunction may contribute to AD pathogenesis through several mechanisms:
- Synaptic Integrity: DCC is enriched at synapses and regulates synaptic plasticity. Loss of DCC signaling may contribute to synaptic degeneration in AD
- Neuronal Migration Defects: Altered DCC-mediated neuronal positioning in AD brains
- Axonal Tract Integrity: DCC deficiency may lead to disruption of major white matter tracts affected in AD
- Dopaminergic Neuron Development: DCC guides mesencephalic dopaminergic neuron axons toward their targets
- Neuroprotection: Netrin-1/DCC signaling provides neuroprotective effects against dopaminergic neuron degeneration
- Axonal Maintenance: DCC may help maintain axonal integrity of nigrostriatal pathway
- Motor Neuron Connectivity: DCC-mediated axon guidance is critical for motor neuron circuit formation
- Axonal Degeneration: Loss of DCC function may contribute to progressive motor neuron axon degeneration
- Congenital Mirror Movements: Heterozygous DCC mutations cause mirror movements due to bilateral corticospinal tract projections
- Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS): DCC mutations disrupt ocular motor and spinal cord development
DCC expression is highest during development and remains detectable in the adult brain:
- Developmental Expression: High in fetal brain, especially in regions undergoing neurogenesis and axon pathfinding
- Adult Expression:
- Cerebral cortex (layers II-III, V)
- Hippocampus (CA3, dentate gyrus)
- Cerebellum (Purkinje cells)
- Substantia nigra (dopaminergic neurons)
- Spinal cord (motor neurons)
- No FDA-approved drugs directly target DCC
- Netrin-1/DCC modulation is an active area of research
- Netrin-1 Agonists: Recombinant netrin-1 or small molecule agonists could enhance DCC-mediated neuroprotection
- DCC Agonistic Antibodies: Engineered antibodies that activate DCC signaling without netrin-1
- Downstream Pathway Modulators: Targeting FAK, PI3K/AKT, or MAPK/ERK to enhance pro-survival signaling
- DCC's dual function (survival vs. death) makes targeting complex
- Systemic administration may affect non-neuronal tissues
- Blood-brain barrier penetration required for CNS delivery
The study of Dcc Netrin 1 Receptor Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- DCC Netrin-1 receptor structure and function (Nature, 2017)
- DCC in neuronal development (Neuron, 2015)
- Dependence receptor function of DCC (Cell, 2002)
- DCC mutations and mirror movements (Brain, 2017)
- Netrin-1 neuroprotection in Parkinson's disease (Nat Neurosci, 2014)
- DCC and synaptic plasticity (J Neurosci, 2018)
- FAK signaling downstream of DCC (Cell, 2007)
- DCC in Alzheimer's disease (Acta Neuropathol, 2019)